AIM ImmunoTech Inc. revenue breakdown overview

AIM ImmunoTech Inc. revenue for the last year amounted to 202.00 k USD, the most of which — 202.00 k USD — came from its highest performing source at the moment, Ampligen and Other Drugs, the year earlier bringing 141.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought AIM ImmunoTech Inc. 202.00 k USD, and the year before that — 141.00 k USD.